Menu

Sumitomo Is Thirty-Second Company to Implement Contract Pharmacy Restrictions

Rich Daly, Editor in Chief 340B Report Views
Sumitomo is the 32nd pharmaceutical manufacturer to place restrictions on 340B drug shipment in the contract pharmacy setting.
Drugmaker Sumitomo Pharma America (SMPA) announced it will implement first-time contract pharmacy restrictions next month. The biotech company, which is [...]

Please Login or Become a Paid Subscriber to View this Content

…
Read More »

Astellas Adds Second Drug to 340B Contract Pharmacy Restrictions

William Newton, Editor-in-Chief 340B Report Views
Pharmaceutical manufacturer Astellas recently added a second medication to its 340B contract pharmacy restrictions.
Japanese drugmaker Astellas will soon extend its limits on 340B pricing to hospitals for its medication to treat overreactive bladder, [...]

Please Login or Become a Paid Subscriber to View this Content

…
Read More »

Amgen, J&J to Issue Refunds on High-Selling Drugs to 340B Providers

Rich Daly, Editor in Chief 340B Report Views
Drugmakers Amgen and Johnson & Johnson have announced they will provide refunds to 340B providers on past purchases of multiple [...]

Please Login or Become a Paid Subscriber to View this Content

…
Read More »

Estimated 340B Revenue Exceeded Charity Care Spending for 85% of DSH Hospitals, Says Pharma-backed Group

Rich Daly, Editor in Chief 340B Report Views
340B revenue exceeds charity care spending for most DSH hospitals, said a report from drug industry-backed AIR340B.
Eighty-five percent of DSH hospitals earned more in estimated 340B revenue in 2022 than they incurred in charity care costs, [...]

Please Login or Become a Paid Subscriber to View this Content

…
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live